Key result
Right ventricular dysfunction was associated with increased 60-day mortality among ICU patients with COVID-19.
Why the study?
RV dysfunction is common among patients hospitalized with COVID-19, but its epidemiology may depend on the echocardiographic parameters used to define it.
Does right ventricular dysfunction predict 60-day mortality in ICU patients with COVID-19?
Cohort (n=116)
Does right ventricular dysfunction predict 60-day mortality in ICU patients with COVID-19?
In ICU patients with COVID-19, right ventricular dysfunction is highly prevalent and significantly associated with increased 60-day mortality, highlighting the importance of multiparametric echocardiographic evaluation.
Answers are grounded in this paper and cite their sources.
RV dysfunction by multiple echo parameters was associated with 60-day mortality in COVID-19 ICU; leaves open standardized multi-parameter definitions for future prognostic studies.
Rationale Right ventricular (RV) dysfunction is common among patients hospitalized with coronavirus disease (COVID-19); however, its epidemiology may depend on the echocardiographic parameters used to define it. Objectives To evaluate the prevalence of abnormalities in three common echocardiographic parameters of RV function among patients with COVID-19 admitted to the intensive care unit (ICU), as well as the effect of RV dilatation on differential parameter abnormality and the association of RV dysfunction with 60-day mortality. Methods We conducted a retrospective cohort study of ICU patients with COVID-19 between March 4, 2020, and March 4, 2021, who received a transthoracic echocardiogram within 48 hours before to at most 7 days after ICU admission. RV dysfunction and dilatation, respectively, were defined by guideline thresholds for tricuspid annular plane systolic excursion (TAPSE), RV fractional area change, RV free wall longitudinal strain (RVFWS), and RV basal dimension or RV end-diastolic area. Association of RV dysfunction with 60-day mortality was assessed through logistic regression adjusting for age, prior history of congestive heart failure, invasive ventilation at the time of transthoracic echocardiogram, and Acute Physiology and Chronic Health Evaluation II score. Results A total of 116 patients were included, of whom 69% had RV dysfunction by one or more parameters, and 36.3% of these had RV dilatation. The three most common patterns of RV dysfunction were the presence of three abnormalities, the combination of abnormal RVFWS and TAPSE, and isolated TAPSE abnormality. Patients with RV dilatation had worse RV fractional area change (24% vs. 36%; P = 0.001), worse RVFWS (16.3% vs. 19.1%; P = 0.005), higher RV systolic pressure (45 mm Hg vs. 31 mm Hg; P = 0.001) but similar TAPSE (13 mm vs. 13 mm; P = 0.30) compared with those with normal RV size. After multivariable adjustment, 60-day mortality was significantly associated with RV dysfunction (odds ratio, 2.91; 95% confidence interval, 1.01–9.44), as was the presence of at least two parameter abnormalities. Conclusions ICU patients with COVID-19 had significant heterogeneity in RV function abnormalities present with different patterns associated with RV dilatation. RV dysfunction by any parameter was associated with increased mortality. Therefore, a multiparameter evaluation may be critical in recognizing RV dysfunction in COVID-19.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2023) conducted a cohort in COVID-19 in the intensive care unit (n=116). Right ventricular dysfunction vs. No right ventricular dysfunction was evaluated on 60-day mortality (OR 2.91, 95% CI 1.01-9.44). Right ventricular dysfunction was associated with increased 60-day mortality among ICU patients with COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: